About this trial
Indigenous people living in Canada face significant healthcare inequities, particularly in basic, primary, and secondary prevention, leading to higher rates of cardiovascular disease and mortality. This program aims to develop a comprehensive understanding of the contextual and individual determinants influencing Indigenous health, and to address health disparities by using tailored community-led participatory research and care initiatives. The investigator and research team use a Mobile Healthcare Unit travelling to Indigenous communities, providing customized, impactful, and sustainable preventive care that adapts dynamically to the evolving needs of each community. The initiative places a strong emphasis on equity and inclusivity, aiming to generate original data in Indigenous and remote underrepresented/underserved populations. This proposal will improve opportunities of identifying facilitators and barriers to preventive care in Indigenous and remote communities. This focus is vital for reducing health disparities and aligns with the Truth and Reconciliation Calls to Action. To maximize knowledge mobilization and ensure culturally appropriate initiatives align with community needs and priorities, this research program collaborates with the Indigenous University Hub at Laval University, local community members and leaders, and Indigenous peoples with lived experience. Existing national and international collaborations with Indigenous communities further enhance the initiative's potential impact and foster knowledge mobilization on a global scale. The ultimate goal is to empower Indigenous peoples and communities to advocate for systemic changes to fight inequities in healthcare in accordance with appropriated truth and reconciliation efforts.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
BMI > 27 kg/m²
Disqualifiers
Being pregnant;
Known heart condition
Trial design
Single group
Treatments tested in this trial
Cardiovascular risk screening
Other interventionExtensive cardiovascular risk screening offered locally in underserved/ underrepresented communities (see Study Description for more details)
Follow-up of cardiovascular risk factors
Other interventionMeasure changes in cardiovascular risk factors among participants who took place in the screening phase.
Treatment groups
Trial outcomes
Primary outcomes
Height in meters
Measured using a stadiometer
Weight in kilograms
Measured using an electronic body scale
Body mass index in kg/(m^2)
BMI will be calculated by dividing the weight in kilograms by the square of the height in meters
Waist circumference in centimeters
Waist circumference will be measured using an ergonomic circumference measuring tape
Secondary outcomes
Participant feedback on intervention
Questionnaire on participant satisfaction and areas of improvement in health equity.
Other outcomes
Body fat distribution
Percentage and kilograms, using a electrical bioimpedance device
Liver fat content
Measured with liver elastography
Arterial stiffness
Measured by pulse wave velocity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Laval University
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator